Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASK0912 vs polymyxin B for multidrug-resistant gram-negative HABP
CTR20254975Phase 2Active
- Sponsor
- Aosaikang Biotherapeutics
- Start
- Jan 2026
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of ASK0912 in bacterial pneumonia, sponsored by Aosaikang Biotherapeutics. Started Jan 2026; status: active.
02
Drugs
ASK0912
03
Conditions
bacterial pneumonia
Beyond the preview
Go deeper on CTR20254975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254975.